AAAAAA
Results:
1-21
|
Results: 21
Authors:
LALEZARI JP
HOLLAND GN
KRAMER F
MCKINLEY GF
KEMPER CA
IVES DV
NELSON R
HARDY WD
KUPPERMANN BD
NORTHFELT DW
YOULE M
JOHNSON M
LEWIS RA
WEINBERG DV
SIMON GL
WOLITZ RA
RUBY AE
STAGG RJ
JAFFE HS
Citation: Jp. Lalezari et al., RANDOMIZED, CONTROLLED-STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS CIDOFOVIR FOR THE TREATMENT OF RELAPSING CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 339-344
Authors:
PETER K
LALEZARI JP
PEARL JM
THEVANAYAGAM L
GAMBERTOGLIO JG
Citation: K. Peter et al., COMPARISON OF ZIDOVUDINE PHOSPHORYLATION IN LYMPH-NODES AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN HIV-INFECTED PATIENTS, AIDS, 12(13), 1998, pp. 1729-1731
Authors:
GNANN JW
CRUMPACKER CS
LALEZARI JP
SMITH JA
TYRING SK
BAUM KF
BORUCKI MJ
JOSEPH WP
MERTZ GJ
STEIGBIGEL RT
CLOUD GA
SOONG SJ
SHERRILL LC
DEHERTOGH DA
WHITLEY RJ
Citation: Jw. Gnann et al., SORIVUDINE VERSUS ACYCLOVIR FOR TREATMENT OF DERMATOMAL HERPES-ZOSTERIN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS FROM A RANDOMIZED, CONTROLLED CLINICAL-TRIAL, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1139-1145
Authors:
LALEZARI JP
Citation: Jp. Lalezari, CIDOFOVIR - A NEW THERAPY FOR CYTOMEGALOVIRUS RETINITIS, Journal of acquired immune deficiency syndromes and human retrovirology, 14, 1997, pp. 22-26
Authors:
LALEZARI JP
KUPPERMANN BD
Citation: Jp. Lalezari et Bd. Kuppermann, CLINICAL-EXPERIENCE WITH CIDOFOVIR IN THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS, Journal of acquired immune deficiency syndromes and human retrovirology, 14, 1997, pp. 27-31
Authors:
WHITLEY RJ
FRIEDBERG DN
KUPPERMANN BD
LALEZARI JP
SPECTOR SA
HARDY WD
Citation: Rj. Whitley et al., NEW APPROACHES TO THE TREATMENT OF CYTOMEGALOVIRUS-RETINITIS - PROCEEDINGS BASED ON A ROUND-TABLE MEETING HELD IN WASHINGTON, DC, JANUARY 26, 1996 - OPEN DISCUSSION, Journal of acquired immune deficiency syndromes and human retrovirology, 14, 1997, pp. 36-38
Authors:
KUPPERMANN BD
LALEZARI JP
HOLLAND GN
Citation: Bd. Kuppermann et al., RANDOMIZED, CONTROLLED-STUDY OF INTRAVENOUS CIDOFOVIR (CDV) FOR TREATMENT OF RELAPSING CMV RETINITIS - FINAL RESULTS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 4279-4279
Authors:
CHERNOFF DN
MINER RC
HOO BS
SHEN LP
KELSO RJ
JEKICMCMULLEN D
LALEZARI JP
CHOU SW
DREW WL
KOLBERG JA
Citation: Dn. Chernoff et al., QUANTIFICATION OF CYTOMEGALOVIRUS DNA IN PERIPHERAL-BLOOD LEUKOCYTES BY A BRANCHED-DNA SIGNAL AMPLIFICATION ASSAY, Journal of clinical microbiology, 35(11), 1997, pp. 2740-2744
Authors:
CHOU SW
MAROUSEK G
GUENTZEL S
FOLLANSBEE SE
POSCHER ME
LALEZARI JP
MINER RC
DREW WL
Citation: Sw. Chou et al., EVOLUTION OF MUTATIONS CONFERRING MULTIDRUG-RESISTANCE DURING PROPHYLAXIS AND THERAPY FOR CYTOMEGALOVIRUS DISEASE, The Journal of infectious diseases, 176(3), 1997, pp. 786-789
Authors:
JABS DA
MEINERT CL
LALEZARI JP
Citation: Da. Jabs et al., CIDOFOVIR FOR CYTOMEGALOVIRUS RETINITIS - RESPONSE, Annals of internal medicine, 127(6), 1997, pp. 490-491
Authors:
LALEZARI JP
STAGG RJ
KUPPERMANN BD
HOLLAND GN
KRAMER F
IVES DV
YOULE M
ROBINSON MR
DREW WL
JAFFE HS
Citation: Jp. Lalezari et al., INTRAVENOUS CIDOFOVIR FOR PERIPHERAL CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 126(4), 1997, pp. 257
Authors:
LALEZARI JP
Citation: Jp. Lalezari, PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, Current opinion in infectious diseases, 9(6), 1996, pp. 415-419
Authors:
SPECTOR SA
MCKINLEY GF
LALEZARI JP
SAMO T
ANDRUCZK R
FOLLANSBEE S
SPARTI PD
HAVLIR DV
SIMPSON G
BUHLES W
WONG R
STEMPIEN MJ
Citation: Sa. Spector et al., ORAL GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN PERSONS WITH AIDS, The New England journal of medicine, 334(23), 1996, pp. 1491-1497
Authors:
CHERRINGTON JM
MINER R
HITCHCOCK MJM
LALEZARI JP
DREW WL
Citation: Jm. Cherrington et al., SUSCEPTIBILITY OF HUMAN CYTOMEGALOVIRUS TO CIDOFOVIR IS UNCHANGED AFTER LIMITED IN-VIVO EXPOSURE TO VARIOUS CLINICAL REGIMENS OF DRUG, The Journal of infectious diseases, 173(4), 1996, pp. 987-992
Authors:
CUNDY KC
PETTY BG
FLAHERTY J
FISHER PE
POLIS MA
WACHSMAN M
LIETMAN PS
LALEZARI JP
HITCHCOCK MJM
JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF CIDOFOVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(6), 1995, pp. 1247-1252
Authors:
YUEN GJ
DRUSANO GL
FLETCHER C
CAPPARELLI E
CONNOR JD
LALEZARI JP
DREW L
FOLLANSBEE S
BUSCH D
JACOBSON M
SPECTOR SA
SQUIRES K
BUHLES W
Citation: Gj. Yuen et al., POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2350-2352
Authors:
DREW WL
IVES D
LALEZARI JP
CRUMPACKER C
FOLLANSBEE SE
SPECTOR SA
BENSON CA
FRIEDBERG DN
HUBBARD L
STEMPIEN MJ
SHADMAN A
BUHLES W
Citation: Wl. Drew et al., ORAL GANCICLOVIR AS MAINTENANCE TREATMENT FOR CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, The New England journal of medicine, 333(10), 1995, pp. 615-620
Authors:
SPECTOR SA
BUSCH DF
FOLLANSBEE S
SQUIRES K
LALEZARI JP
JACOBSON MA
CONNOR JD
JUNG D
SHADMAN A
MASTRE B
BUHLES W
DREW WL
DANKNER WM
MEIXNER L
FREEMAN WR
DYNER TS
FREEMAN E
MORTILLARO G
GLUTZER E
BUSH T
COLEMAN R
Citation: Sa. Spector et al., PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/, The Journal of infectious diseases, 171(6), 1995, pp. 1431-1437
Authors:
LALEZARI JP
DREW WL
GLUTZER E
JAMES C
MINER D
FLAHERTY J
FISHER PE
CUNDY K
HANNIGAN J
MARTIN JC
JAFFE HS
Citation: Jp. Lalezari et al., -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE (CIDOFOVIR) - RESULTS OF A PHASE I II STUDY OF A NOVEL ANTIVIRAL NUCLEOTIDE ANALOG/, The Journal of infectious diseases, 171(4), 1995, pp. 788-796
Authors:
LALEZARI JP
DREW WL
GLUTZER E
MINER D
SAFRIN S
OWEN WF
DAVIDSON JM
FISHER PE
JAFFE HS
Citation: Jp. Lalezari et al., TREATMENT WITH INTRAVENOUS -1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS INFECTION WITH HERPES-SIMPLEX VIRUS IN A PATIENT WITH AIDS, The Journal of infectious diseases, 170(3), 1994, pp. 570-572
Authors:
FISCHL MA
OLSON RM
FOLLANSBEE SE
LALEZARI JP
HENRY DH
FRAME PT
REMICK SC
SALGO MP
LIN AH
NAUSSKAROL C
LIEBERMAN J
SOO WJ
Citation: Ma. Fischl et al., ZALCITABINE COMPARED WITH ZIDOVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION WHO RECEIVED PREVIOUS ZIDOVUDINE THERAPY, Annals of internal medicine, 118(10), 1993, pp. 762-769
Risultati:
1-21
|